8-K/A: Banzai Corrects Note Maturity Date in SEC Filing

Banzai International, Inc. filed an amendment to correct the maturity date of its recently issued senior secured convertible notes from 18 months to 12 months.

Summary

• Banzai International, Inc. filed an 8-K/A to correct a scrivener's error in its July 3, 2025, 8-K filing regarding the maturity date of senior secured convertible notes.
• The corrected maturity date for the notes is June 30, 2026, shortened from the previously stated December 30, 2026.
• The original filing detailed a private placement (Offering) of senior secured convertible notes with an aggregate original principal amount of U.S. $11,000,000.
• The notes were issued with a 10.0% Original Issue Discount (OID) and accrue interest at a rate of 10.0% per annum.
• The conversion price of the notes is subject to a floor price of $0.11 per share.
• The company received approximately $1.725 million in initial net proceeds from the offering, after deducting financial advisory fees and estimated offering expenses.
• The offering also included Buyer Warrants to acquire up to 671,243 shares of Common Stock at an exercise price of $0.66 per share, and Financial Advisor Warrants for up to 212,121 shares at $0.8250 per share.
• Monthly principal payments of $183,333.33, plus accrued interest, are scheduled to begin on August 1, 2025, payable in cash or shares at the company's option, subject to certain conditions.

Sentiment

Score: 6

Explanation: The filing is an amendment correcting a minor error in a previously announced financing, which is a neutral to slightly negative administrative point. However, the underlying financing itself is positive for the company's liquidity and working capital, albeit with significant dilution and high financing costs. The correction of the maturity date from 18 months to 12 months is a material change for debt holders, but for the company, it means a shorter repayment period, which could be seen as a slight negative for cash flow management, but it's a correction to the actual term, not a change in terms. The overall sentiment is moderately positive due to the capital raise, tempered by the high cost of capital and the administrative error.

Positives

• The private placement successfully raised U.S. $11,000,000 in gross proceeds, providing approximately $1.725 million in net proceeds for general corporate purposes and working capital.
• The notes are senior secured, offering a level of security to the noteholders, which can attract investors.
• The company retains flexibility to pay monthly installments in cash or shares, provided certain equity conditions are satisfied.
• The conversion price includes a floor of $0.11, which provides some protection against excessive dilution for the company in a declining stock price scenario.

Negatives

• The issuance of convertible notes and warrants will lead to potential significant dilution for existing shareholders upon conversion or exercise.
• The notes were issued with a 10.0% Original Issue Discount (OID), meaning the company received less cash than the principal amount of the debt.
• The notes carry a high interest rate of 10.0% per annum, increasing the company's debt servicing costs.
• Substantial fees were paid to the financial advisor, including a 7% cash fee, a 1.0% management fee, a $75,000 expense allowance, and additional warrants.
• The filing is an amendment to correct a 'scrivener's error' regarding the maturity date, indicating a potential oversight in the initial disclosure.
• The notes include provisions for redemption at a premium (15% for Event of Default, 30% for Change of Control) if certain events occur, which could be costly for the company.
• The company is restricted from issuing certain other securities or filing other registration statements until the current registration statement is effective, limiting financing flexibility.

Risks

• Dilution Risk: Conversion of the notes and exercise of the warrants will increase the number of outstanding common shares, diluting the ownership percentage of existing shareholders.
• Financial Covenants Risk: The company is subject to various covenants, including restrictions on incurring additional indebtedness, placing liens on assets, making restricted payments, transferring assets, and changing its business nature. Breach of these covenants could trigger an Event of Default.
• Event of Default Risk: Failure to meet obligations such as timely share delivery upon conversion, payment of amounts due, or maintaining listing on an Eligible Market could trigger an Event of Default, allowing noteholders to demand redemption at a premium or convert at an unfavorable rate.
• Liquidity Risk: The company's ability to make cash payments for monthly installments or redemptions depends on its future cash flow and financial performance.
• Market Price Volatility: The conversion terms and potential redemption prices are tied to the common stock's market price, exposing the company to risks associated with stock price fluctuations.
• Registration Statement Risk: Failure to file or achieve effectiveness of the required registration statement in a timely manner could constitute an Event of Default.
• Authorized Share Failure: If the company does not have a sufficient number of authorized and unreserved shares of Common Stock, it may be required to pay cash in exchange for the redemption of notes, potentially at a higher cost.

Future Outlook

The company intends to use the net proceeds from the offering for general corporate purposes and working capital. It is committed to filing a registration statement for the resale of shares underlying the notes and warrants no later than 30 days after July 30, 2025, and to use best efforts to have it declared effective within 60-90 days.

Management Comments

• Joseph Davy, Chief Executive Officer, signed the filing on behalf of Banzai International, Inc.

Industry Context

This filing details a specific financing transaction, a private placement of convertible notes and warrants, which is a common method for growth-stage companies to raise capital. The terms, including the OID, interest rate, and conversion features, are typical for such instruments, reflecting the balance between investor returns and company flexibility. The correction of a 'scrivener's error' highlights the importance of precision in financial disclosures, a standard expectation across the industry.

Comparison to Industry Standards

• The 10.0% Original Issue Discount (OID) and 10.0% annual interest rate on the convertible notes are relatively high, suggesting either a higher perceived risk by investors or a strong need for capital by the company, which can be common for smaller or growth-stage companies compared to established, lower-risk entities.
• The 7% cash fee and 1% management fee, plus warrants, paid to the financial advisor are within the typical range for private placements, especially for smaller deal sizes where advisory fees can represent a larger percentage of gross proceeds compared to large public offerings.
• The 4.99% (or 9.99%) beneficial ownership limitation for the buyer is a standard provision in private placements to avoid triggering certain SEC reporting requirements (e.g., Schedule 13D) or change of control provisions.
• The inclusion of a floor price ($0.11) on the conversion price is a common anti-dilution measure for the company, protecting against excessive dilution if the stock price drops significantly.
• The requirement for a registration rights agreement and the specified timelines for filing and effectiveness are standard practice to ensure liquidity for investors in privately placed securities.

Corporate Governance

Stakeholder Impact

• Shareholders: Face significant potential for dilution due to the conversion of notes and exercise of warrants. The high cost of capital (OID, interest rate, fees) will impact the company's financial performance and potentially future earnings per share.
• Noteholders (Buyer): Benefit from the senior secured status, a high interest rate, and potential for significant returns through conversion or redemption premiums. They also have strong protective covenants and remedies in case of default.
• Financial Advisor (Rodman & Renshaw LLC): Received substantial fees and warrants, indicating a positive financial outcome for their advisory services.
• Employees/Customers/Suppliers: Indirectly impacted by the capital raise, which provides working capital and supports general corporate purposes, potentially stabilizing operations and future growth initiatives.

Next Steps

• The company is required to prepare and file a registration statement for the resale of Conversion Shares, Warrant Shares, and Financial Advisor Warrants shares no later than 30 days after July 30, 2025.
• The company must use its best efforts to have the registration statement declared effective as promptly as practical, and in any event no later than 60 days (or 90 days for full SEC review) following July 30, 2025.
• Monthly principal payments of $183,333.33 plus accrued interest on the notes are scheduled to commence on August 1, 2025.

Key Dates

Recommendation

The filing is an amendment correcting a factual error, which is a neutral event. The underlying transaction, a private placement of convertible notes and warrants, provides necessary capital for the company's operations and working capital, which is a positive for its immediate stability. However, the terms of the financing are quite expensive (10% OID, 10% interest, significant fees, and potential for substantial dilution), indicating a high cost of capital. While the capital raise addresses immediate funding needs, the dilutive nature and high financing costs could weigh on future share price performance. Given the mixed implications, a 'hold' recommendation is appropriate, advising investors to monitor the company's execution with the new capital and its ability to manage the debt obligations and dilution.

Keywords

Banzai International, BNZI, SEC Filing, 8-K/A, Convertible Notes, Private Placement, Warrants, Capital Raise, Dilution, Corporate Finance, Debt Financing, Equity Financing, SEC Compliance, Financial Reporting